US Markets Open

AI-assisted · Not financial adviceNot advice

AI-assisted · Not financial advice.

US Markets Open

AI-assisted · Not financial adviceNot advice

US Markets Open

AI-assisted · Not financial adviceNot advice

$UNH

Name: UNH (UnitedHealth) — Market Sentiment & Discussion
Creator: MarketMind
License: https://stockmarketsentimentai.com/methodology

UnitedHealth· 6/4/2026, 6:17:04 PM

Analyst & Event Activity

Analyst Rating Changes

Jun 1Truist SecuritiesBuy (reiterated)

May 27BernsteinOutperform (reiterated)

May 26BarclaysOverweight (reiterated)

May 22UBSBuy (reiterated)

May 20MizuhoOutperform (reiterated)

Reddit: MixedAttention: Elevated

Community Take (7D)

Criticism of UNH's complex portfolios contrasts with scrutiny following Berkshire's exit, indicating potential risks for investors.

The Story

News Summary

UNH faces scrutiny after Berkshire exits stake

Key Events

May 18:UNH shares fell over 2% after Berkshire Hathaway disclosed it sold its stake.
May 19:UNH is under scrutiny following Berkshire's exit, leading to surprise selling.
May 20:Mizuho raises price target on UNH to $440 from $410.

Sentiment: 70% bearish / 30% neutral (early) → 60% bullish / 40% neutral (late)

Impact: Initially focused on negative sentiment due to Berkshire's exit, the narrative shifted towards a more positive outlook with the price target increase.

Risks: market volatility, regulatory scrutiny

Analyst ConsensusBuy (52 analysts)

Target: $412 avg (+4% upside)

42 Buy · 6 Hold · 4 Sell

Signal

Divided

Confidence

60%

Based on curated news sources (not retail comments)

Over the last 7 days: While analysts remain optimistic about UnitedHealth's growth potential, the exit of Berkshire Hathaway raises significant concerns about investor confidence.

SentimentNeutral

AnalysisHype

Bullish Factors

✓Mizuho raised its price target on UnitedHealth Group to $440 from $410 and kept an Outperform rating.
✓Wall Street analysts project further momentum for UnitedHealth stock over the next 12 months.

Risk Factors

✗UnitedHealth shares fell after Berkshire Hathaway disclosed it had exited its entire position in the company.

Analyst target

4% upside · 8 analysts · $345–$492 range

▲ $412

Earnings

EPS: $18.38 → $20.88 (2026 vs 2027)

▲ Expected to grow 14%

Insiders (90d)

0 buys, 1 sell

Last: SELL Apr 23· 42d ago

▼Net selling $284K

Analyze with AI yahoo!finance Reddit Answers

AI-assisted · Not financial advice.

$UNH - UnitedHealth | MarketMind | MarketMind

$UNH

UnitedHealth· 6/4/2026, 6:17:04 PM

Analyst & Event Activity

Analyst Rating Changes

Jun 1Truist SecuritiesBuy (reiterated)

May 27BernsteinOutperform (reiterated)

May 26BarclaysOverweight (reiterated)

May 22UBSBuy (reiterated)

May 20MizuhoOutperform (reiterated)

Reddit: MixedAttention: Elevated

Community Take (7D)

Criticism of UNH's complex portfolios contrasts with scrutiny following Berkshire's exit, indicating potential risks for investors.

The Story

News Summary

UNH faces scrutiny after Berkshire exits stake

Key Events

May 18:UNH shares fell over 2% after Berkshire Hathaway disclosed it sold its stake.
May 19:UNH is under scrutiny following Berkshire's exit, leading to surprise selling.
May 20:Mizuho raises price target on UNH to $440 from $410.

Sentiment: 70% bearish / 30% neutral (early) → 60% bullish / 40% neutral (late)

Impact: Initially focused on negative sentiment due to Berkshire's exit, the narrative shifted towards a more positive outlook with the price target increase.

Risks: market volatility, regulatory scrutiny

Analyst ConsensusBuy (52 analysts)

Target: $412 avg (+4% upside)

42 Buy · 6 Hold · 4 Sell

Signal

Divided

Confidence

60%

Based on curated news sources (not retail comments)

Over the last 7 days: While analysts remain optimistic about UnitedHealth's growth potential, the exit of Berkshire Hathaway raises significant concerns about investor confidence.

SentimentNeutral

AnalysisHype

Bullish Factors

✓Mizuho raised its price target on UnitedHealth Group to $440 from $410 and kept an Outperform rating.
✓Wall Street analysts project further momentum for UnitedHealth stock over the next 12 months.

Risk Factors

✗UnitedHealth shares fell after Berkshire Hathaway disclosed it had exited its entire position in the company.

Analyst target

4% upside · 8 analysts · $345–$492 range

▲ $412

Earnings

EPS: $18.38 → $20.88 (2026 vs 2027)

▲ Expected to grow 14%

Insiders (90d)

0 buys, 1 sell

Last: SELL Apr 23· 42d ago

▼Net selling $284K

Analyze with AI yahoo!finance Reddit Answers